Kinaxo’s phosphoproteomics platform, PhosphoScout enables the identification of regulated protein phosphorylation sites in response to therapeutic antibody or kinase inhibitor treatment. Using the quantitative mass spectrometry, up to
The deal adds a new detection platform to the company’s portfolio of assay technologies and creates options for point-of-need test solutions in select markets. ESE’s optical measurement systems
The phase 3 trial will enroll no option as well as poor option patients with chronic and severe ischemia of the lower limb. No option patients are those
According to the company, Zadaxin treatment given with the H1N1 vaccine led to a significant (p value < 0.01) increase in the percentage of subjects who seroconverted at
Symbicort Turbuhaler is a twice-daily treatment for adult bronchial asthma combining budesonide, an inhaled corticosteroid (one dose containing 160µg) and formoterol fumarate dihydrate, a rapid and long acting
In parallel, Biovail Laboratories International, a subsidiary of Biovail, and MedGenesis have concluded an agreement to collaborate on the development of GDNF in parkinson’s disease and potentially other
ImmuKnow assay is a qualitative assay and does not directly quantify the level of immunosuppression. Results of the ImmuKnow assay should be used in conjunction with clinical presentation,
Synergy will be implementing PharmaVigilant’s Inspire EDC System, Clinical Data Warehouse, Investigator Portal and I-Vault eTMF system to support the preparation, conduct and closeout of their phase II
Reportedly, the ability to produce VaxInnate’s recombinant vaccine in a bacterial expression system will enable BE to manufacture vaccine at the company’s existing biotechnology facilities with microbial production
The company said that the new certificate will be valid until November 2014. Jiangbo has another GMP certified factory to produce traditional chinese medicines in tablets, granules, pills,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.